Armata Pharmaceuticals, Inc. (ARMP)
11.55
+0.43
(+3.87%)
USD |
NYAM |
Apr 13, 09:47
Armata Pharmaceuticals EPS Diluted (Quarterly) : -3.42 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| Plus Therapeutics, Inc. | -1.03 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | -1.203 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -124.30M |
| Revenue (Quarterly) | 1.085M |
| Total Expenses (Quarterly) | 125.38M |
| Enterprise Value | 686.69M |
| Gross Profit Margin (Quarterly) | 61.47% |
| Profit Margin (Quarterly) | -11.46K% |
| Earnings Yield | -41.45% |
| Normalized Earnings Yield | -20.36 |